Market closed
Maravai LifeSciences/$MRVI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Maravai LifeSciences
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Ticker
$MRVI
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
570
Website
MRVI Metrics
BasicAdvanced
$247M
-
-$1.05
-
-
Price and volume
Market cap
$247M
52-week high
$11.56
52-week low
$1.68
Average daily volume
3.3M
Financial strength
Current ratio
7.533
Quick ratio
6.372
Long term debt to equity
62.885
Total debt to equity
65.261
Interest coverage (TTM)
-1.52%
Management effectiveness
Return on assets (TTM)
-3.64%
Return on equity (TTM)
-37.98%
Valuation
Price to revenue (TTM)
0.915
Price to book
0.75
Price to tangible book (TTM)
-8.27
Price to free cash flow (TTM)
-10.011
Growth
Revenue change (TTM)
-10.30%
Earnings per share change (TTM)
16.41%
3-year revenue growth (CAGR)
-31.30%
3-year earnings per share growth (CAGR)
-12.37%
What the Analysts think about MRVI
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Maravai LifeSciences stock.
MRVI Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
MRVI Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
MRVI News
AllArticlesVideos
Maravai LifeSciences Holdings, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights - MRVI
Accesswire·4 hours ago
ROSEN, A LEADING LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI
GlobeNewsWire·4 hours ago
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Zynex, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZYXI
GlobeNewsWire·5 hours ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Maravai LifeSciences stock?
Maravai LifeSciences (MRVI) has a market cap of $247M as of April 18, 2025.
What is the P/E ratio for Maravai LifeSciences stock?
The price to earnings (P/E) ratio for Maravai LifeSciences (MRVI) stock is 0 as of April 18, 2025.
Does Maravai LifeSciences stock pay dividends?
No, Maravai LifeSciences (MRVI) stock does not pay dividends to its shareholders as of April 18, 2025.
When is the next Maravai LifeSciences dividend payment date?
Maravai LifeSciences (MRVI) stock does not pay dividends to its shareholders.
What is the beta indicator for Maravai LifeSciences?
Maravai LifeSciences (MRVI) does not currently have a Beta indicator.